반다 파마슈티컬스(Vanda Pharmaceuticals)
DE ˙ DB ˙ US9216591084
€5.26 ↑0.09 (1.74%)
2026-06-05
주가
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership440,794 shares
Latest Disclosed Value $ 3,045,887
Morgan Stanley reports 25.67% decrease in ownership of VM4 / Vanda Pharmaceuticals Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 440,794 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $2,534,566 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 593,023 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of -25.67% during the quarter. The current value of the position is $2,318,576 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 440,794 -152,229 -25.67 3,046 -41.78 0.0002
2026-05-27 2025-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 593,023 -44,476 -6.98 5,230 64.41 0.0003
2026-02-13 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 593,023 -44,476 5,230 0.0003
2026-05-27 2025-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 637,499 -262,978 -29.20 3,181 -25.15 0.0002
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 637,499 -262,978 3,181 0.0002
2025-08-15 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 900,477 -16,243 -1.77 4,250 1.02 0.0003
2025-05-15 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 916,720 -423,783 -31.61 4,208 -34.48 0.0003
2025-05-15 2024-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,340,503 724,082 117.47 6,421 122.10 0.0004
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,340,503 724,082 6,421 0.0004
2025-05-14 2024-09-30 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 616,421 119,201 23.97 2,891 2.92 0.0002
2025-02-14 2024-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 616,421 119,201 2,891 0.0002
2024-11-14 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 616,421 119,201 2,891 0.0000
2025-05-14 2024-06-30 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 497,220 -1,011,428 -67.04 2,809 -54.69 0.0002
2024-10-17 2024-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 497,220 -1,011,428 2,809 0.0002
2024-08-14 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 497,220 -1,011,428 2,809 0.0002
2024-10-17 2024-03-31 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 1,508,648 -514,320 -25.42 6,201 -27.37 0.0005
2024-08-16 2024-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,508,648 -514,320 6,201 0.0005
2024-05-15 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,508,648 -514,320 6,201 0.0005
2024-08-16 2023-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 2,022,968 433,338 27.26 8,537 24.30 0.0008
2024-02-13 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 2,022,968 433,338 8,537 0.0008
2023-11-15 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,589,630 592,987 59.50 6,867 4.57 0.0007
2023-08-14 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 996,643 -252,963 -20.24 6,568 -22.60 0.0006
2023-05-15 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,249,606 465,655 59.40 8,485 46.45 0.0009
2023-02-14 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 783,951 294,678 60.23 5,793 19.86 0.0007
2022-11-14 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 489,273 -184,765 -27.41 4,833 -34.22 0.0007
2022-10-27 2022-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 674,038 261,061 63.21 7,347 57.32 0.0010
2022-08-15 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 674,038 261,061 7,347 0.0010
2022-10-27 2022-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 412,977 123,588 42.71 4,670 2.86 0.0006
2022-05-13 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 412,977 123,588 4,670 0.0006
2022-02-14 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 289,389 41,648 16.81 4,540 6.90 0.0006
2021-11-15 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 247,741 -213,794 -46.32 4,247 -57.22 0.0006
2021-08-23 2021-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 461,535 194,947 73.13 9,928 147.89 0.0013
2021-08-16 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 461,535 194,947 9,928 0.0003
2021-05-17 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 266,588 -630,275 -70.28 4,005 -66.02 0.0006
2021-02-16 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 896,863 611,313 214.08 11,785 327.15 0.0018
2020-11-13 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 285,550 79,722 38.73 2,759 17.20 0.0005
2020-08-14 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 205,828 -379,144 -64.81 2,354 -61.16 0.0005
2020-05-26 2020-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 584,972 -18,087 -3.00 6,060 -38.77 0.0016
2020-05-15 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 584,972 -18,087 6,060 465.5343
2020-02-14 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 603,059 78,490 14.96 9,897 42.10 0.0023
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 524,569 -82,517 -13.59 6,965 -18.58 0.0018
2019-08-14 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 607,086 -20,146 -3.21 8,554 -25.89 0.0023
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 627,232 -34,001 -5.14 11,542 -33.19 0.0033
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 661,233 140,884 27.07 17,277 44.67 0.0052
2019-04-23 2018-09-30 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 520,349 -629,361 -54.74 11,942 -45.48 0.0030
2018-11-20 2018-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 520,349 0 11,942 0.0030
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 520,349 -629,361 11,942
2019-04-23 2018-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,149,710 -83,546 -6.77 21,903 5.40 0.0059
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,149,710 -83,546 21,903
2019-04-23 2018-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,233,256 187,413 17.92 20,781 30.72 0.0058
2018-05-14 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,233,256 187,413 20,781
2019-04-23 2017-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,045,843 -38,879 -3.58 15,897 -18.12 0.0044
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,045,843 -38,879 15,897
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,084,722 -99,611 -8.41 19,416 0.57 0.0058
2017-08-11 2017-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,184,333 -410,163 -25.72 19,305 -13.52 0.0058
2017-05-22 2017-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,594,496 -192,044 -10.75 22,323 -21.66 0.0069
2017-05-12 2017-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,594,496 22,323
2017-02-22 2016-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,786,540 -55,094 -2.99 28,496 -7.01 0.0093
2017-02-13 2016-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,786,540 28,496
2016-11-10 2016-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,841,634 -53,681 -2.83 30,645 44.49 0.0105
2016-08-12 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,895,315 481,506 34.06 21,209 79.45 0.0077
2016-05-12 2016-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,413,809 -22,999 -1.60 11,819 -11.64 0.0045
2016-02-09 2015-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,436,808 -136,092 -8.65 13,376 -24.61 0.0048
2016-02-08 2015-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,572,900 115,389 7.92 17,742 -4.07 0.0066
2015-11-09 2015-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,572,900 17,742
2015-08-12 2015-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,457,511 36,397 2.56 18,495 39.93 0.0064
2015-05-14 2015-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,421,114 -36,604 -2.51 13,217 -36.68 0.0049
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,457,718 728,912 100.01 20,874 175.93 0.0076
2014-12-16 2014-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 728,806 359,833 97.52 7,565 26.17 0.0029
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS COM 921659108 728,806 7,565
2014-05-13 2014-03-31 13F VANDA PHARMACEUTICALS COM 921659108 368,973 45,565 14.09 5,996 49.41 0.0025
2014-02-13 2013-12-31 13F VANDA PHARMACEUTICALS COM 921659108 323,408 159,073 96.80 4,013 122.94 0.0017
2013-11-13 2013-09-30 13F VANDA PHARMACEUTICALS INC C COM 921659108 164,335 133,491 432.79 1,800 620.00 0.0009
2013-08-08 2013-06-30 13F VANDA PHARMACEUTICALS INC C COM 921659108 30,844 30,844 250 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.